Thomas Pabst, Prof
Insel Gruppe AG Bern Switzerland · Department for Medical Oncology; University Hospital/Inselspital · Department of Medical Oncology, University Hospital Bern Switzerland
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Thomas Pabst, Prof as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:04 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06430736 · PRONTO Trial (PRophylactic Versus ON-demand Use of TOcilizumab)Insel Gruppe AG, University Hospital Bern · recruiting · Myeloma, Lymphoma, Leukemia · study chair
- N/ANCT05732688 · Drug-screening in AML at Relapse for Targeted TreatmentInsel Gruppe AG, University Hospital Bern · completed · AML · study chair
- Ph2NCT05636787 · Clinical Trial Investigating the Chemotherapeutic Compound Treosulfan (Trecondi® Ideogen) in Myeloma PatientsInsel Gruppe AG, University Hospital Bern · recruiting · Multiple Myeloma · study chair
- Ph1NCT04496999 · HDM201 and Midostaurin (HDMM) in Relapsed/Refractory AML With FLT3mut and TP53wt.Insel Gruppe AG, University Hospital Bern · terminated · AML, Adult · study chair
- Ph1NCT03491579 · Epacadostat, Cladribine and Cytarabine (ECC) in AMLInsel Gruppe AG, University Hospital Bern · withdrawn · AML, Relapse · study chair
- Ph2NCT02646098 · CD34+ Selected ASCT for Aggressive LymphomasInsel Gruppe AG, University Hospital Bern · completed · Malignant Non-Hodgkin Lymphomas · study chair
- Ph2NCT02278796 · A Trial Comparing the Two High-dose Chemotherapies BeEAM and BEAM Given Before Autologous Stem Cell Transplantation (ASCT) in Lymphoma Patients (BEB-trial)Insel Gruppe AG, University Hospital Bern · completed · Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular, Lymphoma, Mantle-Cell · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:04 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in acute myeloid leukemia.